indication for semaglutide A New (Wegovy) https://bit.ly/3UmgXaj The injectable glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy) has been approved by the FDA to reduce the risk… Maximizing Semaglutide: Understanding the Doses

Its fuel, yesbut its also culture, comfort, and connection

[2] Tran D, Nguyen V, Breck M, Phinney B, Weber D

270,271 GLP-1 or exendin-4 treatment of cultured rat embryonic cerebral cortical cells promoted cell survival during hypoxic injury, and this effect was blocked by GLP-1R antagonists and not seen in GLP-1R knockout mice

A very recent study in healthy European volunteers assessed allulose effects at different doses on background of a 50-g sucrose test solution and observed a significant reduction of plasma glucose peaks at 30 min at the highest allulose doses of 75 and 10 g co-ingested with sucrose (Reference Franchi, Yaranov and Rollini38)

Over months, this compressed schedule can lead to higher average drug concentrations in your system than your starting dose was designed to achieve